Trial intelligence / Profile preview

Long-acting chlorhexidine gel for gingival inflammation in orthodontic patients

RBR-85kywk3Phase 2Completed

Sponsor
Universidade Federal de Minas Gerais
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of chlorhexidine in gingivitis (3 arms), sponsored by Universidade Federal de Minas Gerais. Primary endpoints: Bleeding on probing index and Visible plaque index. Started Jan 2017; status: completed.

02

Drugs

chlorhexidine
03

Conditions

gingivitis

Beyond the preview

Go deeper on RBR-85kywk3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-85kywk3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call